| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.052 | 0.08 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.086 | 0.09 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.086 | 0.09 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |